Literature DB >> 11231843

Pedicled bone flap formation using transplanted bone marrow stromal cells.

M H Mankani1, P H Krebsbach, K Satomura, S A Kuznetsov, R Hoyt, P G Robey.   

Abstract

HYPOTHESIS: Transplanted osteoprogenitor cells derived from cultured bone marrow stromal cells (BMSCs) can be used to fabricate pedicled bone flaps.
DESIGN: Prospective, randomized experimental trials.
SETTING: Basic science research laboratory. MATERIALS: Immunodeficient female NIH-Bg-Nu-Xid mice, aged 3 months. INTERVENTION: The BMSCs were harvested from the long bones of C57Bl/6 transgenic mice carrying the type Ialpha1 collagen-chloramphenicol acetyl transferase reporter gene construct; their numbers were expanded in tissue culture. Treated mice received BMSC transplantations around the common carotid artery and internal jugular vein, the aorta and its venae comitantes, or the saphenous artery and vein; control mice received a sham transplant in comparable recipient sites. MAIN OUTCOME MEASURES: Mice underwent harvesting from 4 weeks to 2 years after transplantation. Transplants were evaluated via histological, immunohistochemical, and angiographic analyses.
RESULTS: Compared with the controls, which formed no bone, 32 of 37 BMSC-containing transplants formed a vascularized bone island that was perfused specifically and solely by its common carotid artery vascular source. Mature transplants consisted of well-developed lamellar, corticocancellous bone whose osteocytes were derived from the grafted BMSCs; hematopoietic tissue derived from the recipient mouse. Transplants formed as early as 4 weeks and remained stable in size as late as 108 weeks.
CONCLUSIONS: Bone marrow stromal cells can be used to create vascularized bone flaps in mice; these bone constructs are vascularized by their pedicle and therefore can potentially be transferred to a recipient site using microsurgical techniques. These findings provide proof of principle of an additional clinical application of BMSC transplantation techniques.

Entities:  

Mesh:

Year:  2001        PMID: 11231843     DOI: 10.1001/archsurg.136.3.263

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Canine cranial reconstruction using autologous bone marrow stromal cells.

Authors:  Mahesh H Mankani; Sergei A Kuznetsov; Brian Shannon; Ravi K Nalla; Robert O Ritchie; Yixian Qin; Pamela Gehron Robey
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Historical review of bone prefabrication.

Authors:  Claudia Di Bella; Enrico Lucarelli; Davide Donati
Journal:  Chir Organi Mov       Date:  2008-08-30

3.  Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions.

Authors:  Mahesh H Mankani; Sergei A Kuznetsov; Grayson W Marshall; Pamela Gehron Robey
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

4.  Where will the stem cells lead us? Prospects for dentistry in the 21 century.

Authors:  S Durga Sreenivas; Akula Sreenivasa Rao; S Sri Satyavani; Bavigadda Harish Reddy; Sanjay Vasudevan
Journal:  J Indian Soc Periodontol       Date:  2011-07

5.  Impact of stem cells in craniofacial regenerative medicine.

Authors:  Pedro A Sanchez-Lara; Hu Zhao; Ruchi Bajpai; Alaa I Abdelhamid; David Warburton
Journal:  Front Physiol       Date:  2012-06-21       Impact factor: 4.566

Review 6.  Tissue engineering of bone: the reconstructive surgeon's point of view.

Authors:  U Kneser; D J Schaefer; E Polykandriotis; R E Horch
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

7.  A prospective Saudi dental stem-cell bank from the perspective of the public and dental practitioners: A cross sectional survey.

Authors:  Rasha K Alomar; Shahad M Aladhyani; Munirah N Aldossary; Sarah A Almohaimel; Mahmoud Salam; Adel F Almutairi
Journal:  J Family Med Prim Care       Date:  2020-02-28

8.  Stem cells in dentistry: knowledge and attitude of Nigerian dentists.

Authors:  Matthew Asizide Sede; Ochuwa Audu; Clement Chinedu Azodo
Journal:  BMC Oral Health       Date:  2013-06-15       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.